Finance

Lists
6919:TPE
Caliway Biopharmaceuticals Co Ltd
NT$ 78.10
-0.51%
(-0.40) 1D
10-р сарын 7, 13:30:11 (GMT+8)  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6919...
Open
NT$ 79.00
High
NT$ 79.10
Low
NT$ 78.10
Mkt. cap
121.62Т
Avg. vol.
8.78 сая
Volume
2.10 сая
52-wk high
NT$ 188.00
52-wk low
NT$ 75.10
EPS
-NT$ 0.17
Open
NT$ 79.00
High
NT$ 79.10
Low
NT$ 78.10
Mkt. cap
121.62Т
Avg. vol.
8.78 сая
Volume
2.10 сая
52-wk high
NT$ 188.00
52-wk low
NT$ 75.10
EPS
-NT$ 0.17
News stories
From web sources and news partners
About Caliway Biopharmaceuticals Co Ltd
CEO-
Employees-
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitecaliwaybiopharma.com
Last report
2026 оны 8-р сарын 11
Fiscal period
Q2 2026
EPS / Est. (TWD)
-NT$ 0.14 / NT$ 2.93
-104.78%miss
Revenue / Est. (TWD)
3.57 сая / 6.01 тэрбум
-99.94%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
13.42 сая
12.41 сая
2.00 мян
3.57 сая
Cost of goods sold
4.09 сая
3.40 сая
1.00 мян.
1.24 сая
Cost of revenue
4.09 сая
3.40 сая
1.00 мян.
1.24 сая
Research and development expenses
244.51 сая
112.62 сая
212.41 сая
210.66 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-33.70 сая
17.06 сая
33.42 сая
54.75 сая
Operating expense
210.81 сая
129.69 сая
245.83 сая
265.41 сая
Total operating expenses
214.89 сая
133.09 сая
245.83 сая
266.65 сая
Operating income
-201.48 сая
-120.68 сая
-245.83 сая
-263.08 сая
Other non operating income
-280.00 мян
9.00 мян
-4.00 мян
-2.00 мян
EBT including unusual items
-7.73 сая
80.19 сая
-107.75 сая
-222.52 сая
EBT excluding unusual items
-7.73 сая
80.19 сая
-107.75 сая
-222.52 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.73 сая
80.19 сая
-107.75 сая
-222.52 сая
Net profit margin
-57.62%
646.17%
-5,387,700.00%
-6,239.93%
Earnings per share
-0.01
0.05
-0.07
-0.14
Interest and investment income
59.73 сая
85.42 сая
78.51 сая
82.27 сая
Interest expense
-34.00 мян
-22.00 мян
-11.00 мян
-329.00 мян
Net interest expenses
59.70 сая
85.40 сая
78.50 сая
81.94 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-195.81 сая
-114.79 сая
-239.81 сая
-258.15 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс